Mercy Adhiambo Ndiege
Research Subjects
Mercy Adhiambo Ndiege has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
A Onyango
Jomo Kenyatta University of Agriculture and Technology
1 shared publicationA Thuita
Jomo Kenyatta University of Agriculture and Technology
1 shared publicationB Kiage
Jomo Kenyatta University of Agriculture and Technology
1 shared publication- Evelyne Nkirote Gikundi
Graduate School of Animal Science and Agriculture Obihiro University of Agriculture and Veterinary Medicine Obihiro Hokkaido Japan
1 shared publication - Josiah Owuor Oyalo
Institute of Food Bio‐resources Technology Dedan Kimathi University of Technology Nyeri Kenya
1 shared publication - Kevin Omondi Aduol
Department of Human Nutrition Sciences, School of Food and Nutrition Sciences Jomo Kenyatta University of Agriculture and Technology (JKUAT) Nairobi Kenya
1 shared publication
Latest Publications
- 19 November 2026
- Published by African Journal of Food, Agriculture, Nutrition and Development in African Journal of Food, Agriculture, Nutrition and Development
- Vol. 26 (9) , 31125-31147
Sociodemographic Factors Associated with Body Composition and Metabolic Syndrome among Type 2 Diabetes Patients at a Level 5 Hospital in Kenya
Metabolic syndrome (MetS) is one of the leading global public health and clinical challenges, with increasing prevalence figures between 10% to 84%. This study explored the association between socio-demographic characteristics both metabolic syndrome and body composition. Sociodemographic characteristics were summarized using descriptive statistics and presented as frequencies and percentages. The prevalence of cardiometabolic risk factors and body composition indicators was calculated and compared between males and females using the Chi-square or Fisher’s exact test, as appropriate, with p-values reported. Multivariable logistic regression analysis was subsequently performed to estimate adjusted associations between socio-demographic factors and cardiometabolic and body composition outcomes, with results presented as odds ratios and 95% confidence intervals. Blood pressure and anthropometric measurements such as waist circumference (WC) and body mass index (BMI) were measured. Data collection methods included a structured questionnaire for sociodemographic data, a bioelectrical impedance machine & anthropometric measurements for body composition and anthropometric data, a digital sphygmomanometer for blood pressure and blood samples for cardiometabolic risk factors using standard laboratory protocols. Highly prevalent body composition and cardiometabolic risk factors were high waist circumference, (65%), waist hip ratios (86.2%), systolic blood pressure (68%) and elevated total body fat percentage (81%) especially in women. The results showed that study participants comprised of 67.2% females and 32.8% males with a mean ± SD of 56.5 years ±10.5, within the range of 20 to 79 years. The presence of MetS was defined using the International Diabetes Federation (IDF) harmonized criteria where 3/5 findings would qualify a person as having MetS. 39 out of 67 participants presented with metabolic syndrome (58.2%). Overall, none of the sociodemographic factors were associated with MetS, however, females had higher odds of developing MetS compared to men, (OR=2.03 p value= 0.243). Similarly, participants aged 60-79years, also had higher odds of developing MetS compared to younger ages (OR=1.15 p value= 0.888), though the associations were not statistically significant. The prevalence of body composition and cardio-metabolic risk factors for metabolic syndrome stratified by gender, showed females had elevated levels of waist to height ratio (p=0.027), WC (p=0.001), total body fat % (p=0.001) and low total body water % (p=0.004), while males reported higher risk of decreased bone mass (p=0.001). In conclusion body composition and cardiometabolic risk factors are higher in women compared to men and older ages compared to younger ages. Key words: Metabolic syndrome, Sociodemographic characteristics; Body composition, Cardiometabolic risk factors
- 19 November 2026
- Published by African Journal of Food, Agriculture, Nutrition and Development in African Journal of Food, Agriculture, Nutrition and Development
- Vol. 26 (9) , 31125-31147
Sociodemographic Factors Associated with Body Composition and Metabolic Syndrome among Type 2 Diabetes Patients at a Level 5 Hospital in Kenya
Metabolic syndrome (MetS) is one of the leading global public health and clinical challenges, with increasing prevalence figures between 10% to 84%. This study explored the association between socio-demographic characteristics both metabolic syndrome and body composition. Sociodemographic characteristics were summarized using descriptive statistics and presented as frequencies and percentages. The prevalence of cardiometabolic risk factors and body composition indicators was calculated and compared between males and females using the Chi-square or Fisher’s exact test, as appropriate, with p-values reported. Multivariable logistic regression analysis was subsequently performed to estimate adjusted associations between socio-demographic factors and cardiometabolic and body composition outcomes, with results presented as odds ratios and 95% confidence intervals. Blood pressure and anthropometric measurements such as waist circumference (WC) and body mass index (BMI) were measured. Data collection methods included a structured questionnaire for sociodemographic data, a bioelectrical impedance machine & anthropometric measurements for body composition and anthropometric data, a digital sphygmomanometer for blood pressure and blood samples for cardiometabolic risk factors using standard laboratory protocols. Highly prevalent body composition and cardiometabolic risk factors were high waist circumference, (65%), waist hip ratios (86.2%), systolic blood pressure (68%) and elevated total body fat percentage (81%) especially in women. The results showed that study participants comprised of 67.2% females and 32.8% males with a mean ± SD of 56.5 years ±10.5, within the range of 20 to 79 years. The presence of MetS was defined using the International Diabetes Federation (IDF) harmonized criteria where 3/5 findings would qualify a person as having MetS. 39 out of 67 participants presented with metabolic syndrome (58.2%). Overall, none of the sociodemographic factors were associated with MetS, however, females had higher odds of developing MetS compared to men, (OR=2.03 p value= 0.243). Similarly, participants aged 60-79years, also had higher odds of developing MetS compared to younger ages (OR=1.15 p value= 0.888), though the associations were not statistically significant. The prevalence of body composition and cardio-metabolic risk factors for metabolic syndrome stratified by gender, showed females had elevated levels of waist to height ratio (p=0.027), WC (p=0.001), total body fat % (p=0.001) and low total body water % (p=0.004), while males reported higher risk of decreased bone mass (p=0.001). In conclusion body composition and cardiometabolic risk factors are higher in women compared to men and older ages compared to younger ages. Key words: Metabolic syndrome, Sociodemographic characteristics; Body composition, Cardiometabolic risk factors
- Open Access
- 26 July 2025
- Published by Wiley in Food Biomacromolecules
Bioactive polysaccharides and their potential health benefits in reducing the risks of metabolic syndrome: A review
Metabolic syndrome (MetS) is a complex noncommunicable condition characterized by central obesity, insulin resistance, hyperlipidemia, hypertension, and hyperglycemia. Epidemiological evidence shows that MetS affects a third of the global population; however, due to its complex pathogenesis and limited drug therapy options, the increasing prevalence is a global public health concern. Consequently, there is increasing interest in natural, novel, safe, and effective supplementary therapies to the existing drug and surgical interventions for treating metabolic diseases. Bioactive polysaccharides characterized by low toxicity, high ubiquity, and physiological properties have attracted much attention in the regulation of MetS. Recently, bioactive polysaccharides have been shown to maintain glucose homeostasis, reduce insulin resistance, and prevent diabetes and obesity complications; however, the mechanisms responsible for specific effects related to the prevention and management of MetS is still unclear. This review discusses the effects and underlying mechanisms of bioactive polysaccharides in preventing and managing metabolic diseases by improving glycolipid metabolism, alleviating systemic inflammation, and modulating gut microbiota. Furthermore, the contribution of the structure‐activity relationship is advanced where possible. The findings on the biomechanisms provide mechanistic insight into the safe and dependable application of bioactive polysaccharides in reducing MetS‐associated risks.
- 26 July 2025
- Published by Wiley in Food Biomacromolecules
Open AccessBioactive polysaccharides and their potential health benefits in reducing the risks of metabolic syndrome: A review
Metabolic syndrome (MetS) is a complex noncommunicable condition characterized by central obesity, insulin resistance, hyperlipidemia, hypertension, and hyperglycemia. Epidemiological evidence shows that MetS affects a third of the global population; however, due to its complex pathogenesis and limited drug therapy options, the increasing prevalence is a global public health concern. Consequently, there is increasing interest in natural, novel, safe, and effective supplementary therapies to the existing drug and surgical interventions for treating metabolic diseases. Bioactive polysaccharides characterized by low toxicity, high ubiquity, and physiological properties have attracted much attention in the regulation of MetS. Recently, bioactive polysaccharides have been shown to maintain glucose homeostasis, reduce insulin resistance, and prevent diabetes and obesity complications; however, the mechanisms responsible for specific effects related to the prevention and management of MetS is still unclear. This review discusses the effects and underlying mechanisms of bioactive polysaccharides in preventing and managing metabolic diseases by improving glycolipid metabolism, alleviating systemic inflammation, and modulating gut microbiota. Furthermore, the contribution of the structure‐activity relationship is advanced where possible. The findings on the biomechanisms provide mechanistic insight into the safe and dependable application of bioactive polysaccharides in reducing MetS‐associated risks.